Endurance RP Ltd
HKEX:575
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Endurance RP Ltd
Cash from Investing Activities
Endurance RP Ltd
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Endurance RP Ltd
HKEX:575
|
Cash from Investing Activities
-$233k
|
CAGR 3-Years
-222%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
Cash from Investing Activities
$2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Cash from Investing Activities
-HK$1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Cash from Investing Activities
-¥7B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-16%
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Cash from Investing Activities
-HK$10.4B
|
CAGR 3-Years
-134%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Cash from Investing Activities
-$29.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Endurance RP Ltd
Glance View
Endurance RP Ltd. is an investment holding company. Along with subsidiaries, the Company operates its business through two segments. The Biopharma segment is engaged in the research, development, manufacture, marketing and sale of pharmaceutical products. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The firm is also engaged in aging research and developing artificial intelligence (AI) models and tool products related to aging research. The company offers aging and longevity clocks to the longevity clinics, preventative medicine organizations, health clubs, insurance companies, and aging research institutions.
See Also
What is Endurance RP Ltd's Cash from Investing Activities?
Cash from Investing Activities
-233k
USD
Based on the financial report for Dec 31, 2025, Endurance RP Ltd's Cash from Investing Activities amounts to -233k USD.
What is Endurance RP Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-222%
Over the last year, the Cash from Investing Activities growth was -7 667%. The average annual Cash from Investing Activities growth rates for Endurance RP Ltd have been -222% over the past three years .
